Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial - Porst, Hartmut; Padma-Nathan, Harin; Giuliano, François; Anglin, Greg; Varanese, Lucio; Rosen, Raymond (Urology (Ridgewood, N.J.), 2003)
Keywords: 3',5'-Cyclic-GMP Phosphodiesterases; Adult; Aged; Aged, 80 and over; Carbolines - administration & dosage; Carbolines - pharmacokinetics; Carbolines - therapeutic use; Cyclic Nucleotide Phosphodiesterases, Type 5; Double-Blind Method; Erectile Dysfunction - drug therapy; Half-Life; Humans; Male; Middle Aged; Patient Satisfaction; Phosphodiesterase Inhibitors - administration & dosage; Phosphodiesterase Inhibitors - pharmacokinetics; Phosphodiesterase Inhibitors - therapeutic use; Phosphoric Diester Hydrolases - drug effects; Tadalafil; Time Factors; Treatment Outcome